Weekly injection for type 1 diabetes and weight
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a weekly injection called tirzepatide to see if it helps people with type 1 diabetes who are overweight or obese. The goal is to improve blood sugar control and help with weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have had type 1 diabetes for at least 12 months.
- Your body mass index (BMI) is 27 or higher.
- Your most recent A1c (a blood sugar test) is 10% or lower.
- You do not take any diabetes medications except insulin.
- You are willing to use a smartphone app to track your diet, keep an exercise log, and share your diabetes device data.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tirzepatide, a medication that helps control blood sugar and weight, can safely improve how your body handles sugar when you have type 1 diabetes. The study looks at short-term effects and may help people who are overweight and use an insulin pump or automated system.
This trial tests if adding tirzepatide (a once-weekly injection) to an automated insulin pump system (Control-IQ) helps adults with type 1 diabetes better manage their blood sugar. It requires using the Tandem Control-IQ pump and counting carbohydrates.
This study tests a weekly injection called tirzepatide in people with type 1 diabetes who are overweight or have obesity. The goal is to see if it helps with blood sugar control and weight loss when added to insulin therapy.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This study tests a once-weekly medicine called tirzepatide to see if it helps control blood sugar and reduce weight in people with type 2 diabetes and obesity. If you qualify, you might get this treatment and be monitored for safety and satisfaction.
This study tests a medication called tirzepatide for people with type 1 diabetes who also have overweight or obesity. Tirzepatide may help with weight loss and blood sugar control, and you'll use a continuous glucose monitor throughout the study.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.